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A randomised controlled trial of breast cancer genetics services in
South East Scotland: psychological impact
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E Anderson4, M Steel5, M Porteous2 and H Campbell*,6
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Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; 3Lothian NHS Board, Deaconess House,
148 Pleasance, Edinburgh EH8 9RS, UK; 4Edinburgh Breast Unit, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK; 5School of
Biology, University of St Andrews, St Andrews, Fife KY16 9TS, UK; 6Department of Public Health Sciences, University of Edinburgh Medical School, Teviot
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This study compared the psychological impact of two models of breast cancer genetics services in South East Scotland. One hundred
and seventy general practices were randomised to refer patients to the existing standard regional service or the novel community-
based service. Participants completed postal questionnaires at baseline (n¼ 373), 4 weeks (n¼ 276) and 6 months (n¼ 263) to
assess perceived risk of breast cancer, subjective and objective understanding of genetics and screening issues, general psychological
distress, cancer worry and health behaviours. For participants in both arms of the trial, there were improvements in subjective and
objective understanding up to 4 weeks which were generally sustained up to 6 months. However, improvements in subjective
understanding for the women at low risk of breast cancer (i.e. not at significantly increased risk) in the standard service arm did not
reach statistical significance. Cancer worry was significantly reduced at 6 months for participants in both arms of the trial. The two
models of cancer genetics services tested were generally comparable in terms of the participants’ psychological outcomes. Therefore,
decisions regarding the implementation of the novel community-based service should be based on the resources required and client
satisfaction with the service.
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Media attention to scientific developments in cancer genetics has
resulted in a greatly increased demand for cancer genetics services.
These services aim to identify individuals who have inherited a
significantly increased risk of cancer in order to counsel them
about their risks and to offer appropriate risk management to
reduce morbidity and mortality. There is a challenge to provide
this information in ways that the lay public can utilise to inform
their health-care choices without causing undue psychological
distress. Individuals who are not at significantly increased risk also
need appropriate reassurance without precluding an appropriate
vigilance to symptoms of sporadic cancer. There is also a challenge
to respond to these new developments within existing health-care
budgets. Internationally, there is a lack of consensus about how
best to deliver cancer genetic services (Steel et al, 1999) and an
urgent need for empirical evidence to inform service development.
A survey of 22 regional cancer genetics services in the UK in
1998 reported that the predominant users of these services were
women with a family history of breast cancer (Wonderling et al,
2001). Of the women who are diagnosed with breast cancer, about
10% report having a family history of the disease (Narod, 2002). Of
these cases, only a small proportion will be due to inherited genetic
mutations in one of the known susceptibility genes, BRCA1 and
BRCA2. These genetic mutations give rise to increased lifetime
risks of developing the disease, often at an earlier age than is the
norm for sporadically occurring cases.
Brain et al (2000) showed that there was no difference in the
effectiveness of multidisciplinary cancer genetics teams and breast
surgeons in terms of psychological outcomes in the management
of familial breast cancer in Wales. Secondary analysis of the data
(Brain et al, 2002) showed some significant differences in
psychological outcomes between groups of women at different
levels of breast cancer risk. Only those women at low or moderate
risk showed significant reductions in cancer worry and perceived
risk of breast cancer. Satisfaction with genetic counselling was
significantly lower in those women found to be at high risk of
breast cancer.
In South East Scotland, a multidisciplinary clinic offering
specialist cancer genetic risk counselling and screening to women
with a family history of breast cancer has been held in the regional
breast screening centre in Edinburgh since 1992. With growing
waiting lists for the South East of Scotland familial breast cancer
clinic, more stringent referral criteria were applied. GPs referring
women judged to be at low risk were sent a letter explaining that
no appointment could be offered when the criteria were not met.
Referrals of women at relatively low risk were still accepted where
the woman’s presentation remained a particular cause of concern
(e.g. high level of anxiety about breast cancer risk which was
difficult for the GP to manage).
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An alternative model of cancer genetics services has been
proposed (Campbell et al, 1995) whereby genetics nurse specialists
could offer clinics within GP locality areas to carry out risk
assessment, provide counselling for those whose risk was not
significantly increased and mediate referral of those at higher risk
to the specialist service. It was hoped this would provide improved
support to primary care and better services for those at lower risk
while encouraging more cost-effective use of specialist resources
for those at increased risk of developing breast cancer.
We carried out a cluster randomised trial of this new model of
service delivery comparing it to the existing multidisciplinary
specialist service. This paper presents a comparison of the
psychological outcomes of these two service models and across
participant’s level of breast cancer risk.
MATERIALS AND METHODS
Participants
Ethical approval for the study was obtained from the local ethics
committee. An invitation to take part in the trial was sent to all
general practices in Lothian (n¼ 125), South West Fife (n¼ 54)
and Borders (n¼ 24) Health Boards in South East Scotland. One
hundred and seventy practices (84%) agreed to take part, 23 (11%)
declined and 10 (5%) did not reply. This meant that 725 of the 828
(88%) GPs in practice across these three Health Boards agreed to
refer patients into the trial. Practices were randomly assigned to
either arm of the trial using a minimisation technique (Pocock,
1983, pp 84–86) to ensure that the two groups were balanced for
size of practice, historical referral rate and social deprivation
index.
During the period March 1998 to November 1999, any woman
referred from participating GP practices to the regional clinical
genetics department for breast cancer genetic risk counselling was
invited to take part in the trial. To be eligible for the trial, women
had to live in the region, be able to give informed consent and had
to complete a baseline questionnaire. Women who were sympto-
matic or had been diagnosed with breast and/or ovarian cancer
were excluded from the trial as were those who had previously
consulted another clinic about their family history of cancer.
Those who were ineligible to participate were offered the standard
regional service.
Procedure
Potential participants were sent an information sheet and were
invited to return the consent form to indicate whether they were
willing to participate in the trial. Those who consented were then
asked to complete a baseline questionnaire. Reminders were sent
to all nonresponders after approximately 4 weeks. Only those who
completed the baseline questionnaire were enrolled in the trial.
Nonresponders and those who did not consent to participate in the
trial were offered the standard regional service. The service offered
to women who returned a completed baseline questionnaire was
dependent on the arm of the trial to which their GP practice had
been randomised.
Standard (regional) service Women were sent a family history
form and a baseline questionnaire to complete. The family history
form requested information about first-, second- and third-degree
relatives. If the family history form was not returned, a letter was
sent to the woman and to her GP to explain that no consultation
was possible without this information. A genetics consultant (MS)
and genetics nurse specialist (JC) assigned categorical risk
assessments informed by published criteria (Table 1) using the
information on the completed family history form. If necessary,
further information and/or confirmation of relatives’ diagnoses
were obtained by a genealogist and from the Scottish Cancer
Registry. When a woman was assessed as being at ‘low risk’ (i.e.
not at significantly increased risk), she and her GP were sent a
letter to explain this. Women assessed as being at ‘moderate’ or
‘high risk’, or where an adequate risk assessment could not be
made from the information available, an appointment at the
familial breast cancer clinic were offered. The clinic consultation
offered more detailed discussion with a genetics consultant about
risk status and with a specialist breast surgeon about options for
risk management (i.e. breast cancer screening and, for ‘high-risk’
women, prophylactic mastectomy or chemoprevention). Clinical
breast examination and mammography (where appropriate) were
carried out at this visit. After this appointment, the patient’s GP
was sent a letter to summarise the issues discussed. All women
were asked to complete a postal follow-up questionnaire 4 weeks
and 6 months later.
Novel (community-based) service All women in this arm of the
trial were sent an initial appointment for one of the community-
based clinics (held in a GP practice near to where they lived), run
by a genetics nurse specialist (RC/RT). At the clinic, the genetics
nurse specialist ascertained the woman’s family history of cancer
and compiled a family tree. This information was compared to
published criteria (Table 1) to determine whether she was at
significantly increased risk. When an adequate risk assessment
could not be made during the appointment, further information
and/or confirmation of relatives’ diagnoses were obtained from the
patient or medical records, before the patient was informed of
their risk by letter. Women deemed not to be at significantly
increased risk (i.e. in the ‘low-risk’ category) were offered
information and reassurance and were discharged from the clinic.
These patients and their GPs were sent a letter reaffirming their
‘low-risk’ status and summarising the issues discussed at the
appointment. Women found to be at increased risk (i.e. in the
‘moderate-risk’ or ‘high-risk’ categories) were offered an appoint-
ment at the regional centre with a geneticist and genetics nurse
specialist. All women were asked to complete a postal follow-up
questionnaire 4 weeks and 6 months later.
Sociodemographic and objective breast cancer risk data
Women were asked to record their date of birth, marital status and
educational level on the baseline questionnaire. Information about
the category of breast cancer risk to which each woman had been
assigned was derived from the clinical records.
Psychological measures
Subjective understanding Women were asked to rate on a 4-point
scale from 1 (not at all) to 4 (very much) how well they understood
each of four issues relevant to breast cancer genetic risk. The issues
were:
1. How increased risk of breast cancer is passed on in families.
2. The significance of their own family history of cancer.
Table 1 Criteria for assessing a significantly increased risk of breast
cancer (Cancer Research Campaign, 1997)
A woman’s risk of developing breast cancer is moderately increased if she has one
of the following:
K A first-degree relative with breast cancer diagnosed under 40 years.
K Two first- or second-degree relatives on the same side of the family with
breast cancer diagnosed under 60 years or with ovarian cancer.
K Three first- or second-degree relatives on the same side of the family with
breast or ovarian cancer.
K A first-degree relative with breast cancer in both breasts.
K A first-degree male relative with breast cancer.
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3. Whether there was anything they could do to reduce their risk
of developing breast cancer.
4. What services were available to protect the health of people at
increased risk of breast cancer.
Responses were summed to give a composite score for subjective
understanding ranging from 4 to 16.
Objective understanding Participants were asked to consider a
number of factual statements and to respond ‘true’, ‘false’ or ‘don’t
know’. There were 10 statements about breast cancer genetics (e.g.
‘Only a parent who has had breast cancer can pass on increased
risk to their children’) and 12 statements about issues surrounding
mammography (e.g. ‘Mammograms are used to detect early stages
of breast cancer’). Statements were scored 1 (correct) or 0
(incorrect/don’t know), and the number of correct responses
combined to give total scores for genetics understanding (range 0–
10) and mammography understanding (range 0 –12).
Perceived risk of breast cancer Although a number of items were
used to assess perceived risk of breast cancer, the results of one
item were analysed for the purposes of this report. Participants
were asked to indicate whether they considered their own level of
risk to be high, moderate or low.
Psychological distress
(i) General Health Questionnaire 30-item version (GHQ-30)
(Goldberg and Williams, 1988). This well-validated scale was
scored using the GHQ method (0, 0, 1, 1) using a threshold of
X6 to screen for ‘case-level’ general psychological distress.
(ii) Cancer Worry Scale (Watson et al, 1998). This six-item scale
(adapted from four single items, Lerman et al, 1991a, b)
assesses concerns about developing cancer and their impact
on daily functioning. Total scores range from 6 to 24 where a
higher score indicates higher levels of worry. The psycho-
metric properties of the scale have been shown to be
satisfactory (Brain et al, 1999; Hopwood et al, 2001).
Health behaviours Several ad-hoc items indicated the extent to
which genetic counselling may have influenced the women’s health
behaviour. Participants at 4 weeks were asked retrospectively
about their health behaviours prior to counselling (i.e. the
frequency of breast self-examination, smoking, drinking alcohol,
trying to lose weight, eating bran and high-fibre foods, avoiding
fatty foods, eating a balanced diet, taking exercise, looking after
their health in general). They were asked to rate whether the
frequency of any of these behaviours had changed since consulting
genetics services (at 4 weeks) or in the last 6 months (at 6 months)
on a scale from 1 (much less than before) to 5 (much more than
before).
Statistical methods
Descriptive statistics were generated to describe the study
participants. Differences between two independent groups were
analysed with independent samples t-tests (two-tailed), Mann–
Whitney, w2 (two-tailed) or Fisher’s exact tests (two-tailed). A 2
(trial arm) 2 (objective risk) repeated measures analysis of
variance (ANOVA) was used to determine between-group
differences and within-group changes over time (baseline, 4
weeks, 6 months) in psychological outcomes and possible
interactions between trial arm, objective risk and time. Significant
effects were followed up with post-hoc tests (independent samples
t-tests, paired t-tests, ANOVA). w2 (two-tailed), Fisher’s exact (two-
tailed), Cochran’s and McNemar tests were used to examine the
impact of time, trial arm and objective risk on perceived risk and
the proportion of participants suffering from ‘case-level’ distress.
A significance level of 0.05 was used throughout. The data were
analysed using SPSS for Windows version 10.00 (1999).
RESULTS
Participants
Figure 1 shows the progress of participants through each arm of
the trial.
Baseline Over the study period, 574 women, referred for breast
cancer genetic risk counselling, were invited to participate in the
trial. Consent forms were returned by 451 women (response rate
79%), of whom 428 (75% of those invited) agreed to participate in
the study. Three hundred and seventy-three of these women (87%
of those who consented) returned a completed baseline ques-
tionnaire, 185 of whom were then assigned to the standard service
arm and 188 to the novel service arm of the trial according to their
GP practice.
4 weeks Of the 373 women who completed a baseline ques-
tionnaire, 276 also completed a 4 week follow-up questionnaire
(74% of those who were enrolled in the trial), 147 from the
Invited to participate (n = 574)
Excluded (n = 201) 
− refused to participate (n = 23)
− not responded (n = 123) 
− not returned baseline   
questionnaire (n = 31) 
− administrative reasons (n = 11)
− protocol violation (n = 13)a
4 week follow-up (n = 147) 
Excluded (n = 38): 
− lost to follow-up (n = 6) 
− not returned questionnaire 
   (n = 15) 
− withdrew (n = 2)  
− clinical reasons (n = 4)b 
− administrative reasons (n =11) 
Consented, completed baseline 
questionnaire and randomised 
according to GP practice 
(n = 373)
4 week follow-up (n = 129) 
Excluded(n = 59): 
− lost to follow-up (n = 13)  
− not returned questionnaire  
  (n = 22) 
− withdrew (n = 5) 
− clinical reasons (n = 5)b
− administrative reasons (n =14)
6 month follow-up (n = 140)c
Excluded (n =16):  
− not returned questionnaire   
   (n = 14)  
− returned questionnaire blank 
(n = 1) 
− administrative reasons (n = 1)
6 month follow-up (n = 123)d
Excluded (n = 16): 
− not returned questionnaire
  (n = 14) 
− withdrew (n = 1) 
− administrative reasons (n = 1)
Completed trial (n = 113) Completed trial (n = 131) 
Standard service arm (n = 185) Novel service arm (n = 188)
Figure 1 Progress of participants through the trial.
a For example, the women had received genetic counselling elsewhere or
had been treated for cancer.
b For example investigation of breast symptoms.
c Includes nine women who were excluded at the 4 week assessment due
to administrative reasons (n¼ 5) or nonreturn of the questionnaire (n¼ 4).
d Includes 10 women who were excluded at the 4 week assessment due to
administrative reasons (n¼ 4) or nonreturn of the questionnaire (n¼ 6).
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standard service arm and 129 from the novel service arm of the
trial.
The characteristics of those for whom only baseline data were
available (‘baseline only group’; n¼ 97) were compared with those
of the ‘4 week group’ (n¼ 276) to check for participation bias. A
significantly greater number of the ‘baseline only group’ had been
assigned to the novel service arm than the standard service arm of
the trial (61 vs 39%; w2¼ 5.70, df¼ 1, P¼ 0.018). A higher
proportion of women in the ‘baseline only group’ were categorised
as being at low risk (54 vs 32%; w2¼ 14.01, df¼ 1, Po0.000).
Similarly, a greater proportion of women in this group were
suffering from ‘case-level’ distress at baseline (43 vs 31%; w2¼ 4.53,
df¼ 1, P¼ 0.043). The ‘baseline only group’ had significantly
higher scores at baseline on the Cancer Worry Scale
(mean¼ 12.18/11.10; s.d.¼ 3.29/2.98; t¼ 2.97, df¼ 367,
P¼ 0.003). There were no significant differences between the two
groups on any of the other sociodemographic or psychological
variables at baseline.
6 months Two hundred and sixty-three women completed 6
month follow-up questionnaires (71% of those who were enrolled
in the trial), 140 women from the standard service arm and 123
from the novel service arm of the trial. This includes 19 women
who were excluded at the 4 week assessment due to administrative
reasons (n¼ 9) or nonreturn of the questionnaire (n¼ 10). The
baseline characteristics of those for whom the 6 month ques-
tionnaires were analysed (‘6 month group’; n¼ 263) were
compared with those participants who completed the 4 week
questionnaire but not the 6 month questionnaire (‘Not 6 month
group’; n¼ 32) to check for participation bias. There were no
significant differences between the number of women who
dropped out from either arm of the trial. A greater proportion of
women in the ‘Not 6 month’ group were classified as being at low
risk of breast cancer (53 vs 31%; w2¼ 6.41, df¼ 1, P¼ 0.016). This
group scored significantly lower on objective understanding of
mammography (t¼2.37, df¼ 270, P¼ 0.018) and had a tendency
to have higher scores on the Cancer Worry Scale (t¼ 1.83,
df¼ 290, P¼ 0.068). There were no significant differences between
the two groups on any of the other sociodemographic or
psychological variables (marital status and perceived risk could
not be analysed due to small numbers in some categories).
Comparison of trial arms on sociodemographic and
objective breast cancer risk characteristics
The sociodemographic characteristics of participants and the
breast cancer risk category to which they were assigned are shown
in Table 2. A greater proportion of women at low risk of breast
cancer were in the novel service arm than the standard service arm
of the trial at baseline (w2¼ 11.86, df¼ 1, P¼ 0.001), 4 weeks
(w2¼ 10.26, df¼ 1, P¼ 0.002) and 6 months (w2¼ 10.52, df¼ 1,
P¼ 0.001). Women with 4 week follow-up data in the novel service
arm were somewhat older than those in the standard service
arm (t¼2.51, df¼ 274, P¼ 0.013). There were no significant
differences between the trial arms on any of the other socio-
demographic variables at the three assessment points.
Table 2 Sociodemographic, objective breast cancer risk and psychological characteristics of the two trial groups at baseline, 4 weeks and 6 monthsa
Baseline (n¼ 373) 4 weeks (n¼ 276) 6 months (n¼ 263)
Variable
Standard service
(n¼ 185)
Novel service
(n¼188)
Standard service
(n¼147)
Novel service
(n¼ 129)
Standard service
(n¼ 140)
Novel service
(n¼ 123)
Age (years): mean (s.d.) 37.3 (9.4) 39.1 (9.6) 36.8 (9.4) 39.7 (9.4)* 37.4 (9.5) 39.5 (9)
Marital status: n (%)
Married/cohabiting 130 (71) 136 (73) 104 (72) 100 (79) 98 (71) 93 (77)
Separated/divorced/widowed 24 (13) 24 (13) 18 (13) 14 (11) 20 (14) 16 (13)
Never married 28 (15) 26 (14) 22 (15) 13 (10) 21 (15) 12 (10)
Education: n (%)
To age 16 years 65 (36) 68 (37) 49 (34) 44 (34) 46 (33) 42 (34)
To age 18 years 30 (17) 28 (15) 23 (16) 19 (15) 23 (17) 15 (12)
After age 18 years 46 (26) 50 (27) 35 (24) 37 (29) 35 (25) 37 (30)
University graduate 39 (22) 40 (22) 36 (25) 28 (22) 34 (25) 28 (23)
Risk of breast cancer: n (%)
Objective:
Low 50 (28)b 81 (46)* 34 (23) 53 (41)* 31 (22) 50 (41)*
Moderate/high 129 (72) 97 (55) 113 (77) 76 (59) 109 (78) 73 (59)
Perceived:
Low 5 (3) 7 (4) 12 (8) 10 (8) 11 (8) 11 (9)
Moderate/high 179 (97) 180 (96) 134 (92) 117 (92) 127 (92) 108 (91)
Understanding: mean (s.d.)
Subjectivec 9.4 (2.8) 8.9 (2.5) 12 (2.2) 11.7 (2.3) 11.9 (2.2) 11.7 (2.3)
Objective:
geneticsd 3.9 (2.5) 3.9 (2.2) 6.3 (2.3) 6 (2.2) 6.3 (2.2) 6 (2.1)
mammographye 7.3 (1.9) 7.0 (1.8) 8 (1.8) 7.8 (1.7) 7.9 (1.8) 7.9 (1.7)
GHQ-30:
Total score: median (IQR) 2 (9) 2 (7.3) 1 (8) 2 (8.5) 0 (4) 0 (5)
‘Case-level’ distress: n (%)f 66 (36) 58 (31) 32 (21) 27 (22) 29 (21) 28 (23)
Cancer worry: mean (s.d.) 11.5 (3.2) 11.3 (3.0) 10.3 (2.4) 10.2 (2.7) 9.9 (2.5) 9.7 (2.7)
aSample size varies due to missing data. bThe majority of women who were assigned a low breast cancer risk in the standard service arm were informed by letter only. cPossible
range of scores: 4 –16. dPossible range of scores: 0–10. ePossible range of scores: 0 –12. fScores of X6. *Po0.05.
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Comparison of trial arms on psychological characteristics
and changes over time (by trial arm and objective breast
cancer risk)
Table 2 shows the psychological characteristics of the women in
the two trial arms at baseline, 4 weeks and 6 months. There were
no significant differences between the two trial arms on any of
these variables at the three assessment points. Table 3 presents the
results of repeated measures ANOVA for the 244 participants (65%
of those who were enrolled in the trial) who completed the
baseline, 4 week and 6 month questionnaires.
Subjective understanding Overall, there was a significant im-
provement in subjective understanding during the course of the
study. Further analysis showed that subjective understanding only
improved to a significant degree between baseline and 4 weeks
(t¼14.97, df¼ 231, Po0.000). Scores on subjective under-
standing were shown to be dependent on objective breast cancer
risk. Post-hoc analysis revealed that women at moderate/high risk
had significantly greater scores on subjective understanding than
those at low risk at 4 weeks (t¼2.69, df¼ 235, P¼ 0.008) and 6
months (t¼2.46, df¼ 109.214, P¼ 0.015). The main effects of
time and objective risk were modified by a significant interaction
between these two factors. Subjective understanding had signifi-
cantly improved for both women at moderate/high risk
(t¼13.70, df¼ 164, Po0.000) and women at low risk
(t¼6.55, df¼ 66, Po0.000) between baseline and 4 weeks.
However, the improvement was significantly greater in women at
moderate/high risk than those at low risk (t¼2.51, df¼ 230,
P¼ 0.013). In addition, there was a significant interaction between
trial arm, time and objective risk. Post-hoc analysis indicated that
differences in subjective understanding between the risk groups
within the different trial arms were significant only between
baseline and 4 weeks (F(1, 226)¼ 5.27, P¼ 0.023). Between these
two time points, the moderate/high-risk women in the standard
service arm (t¼11.64, df¼ 98, Po0.000) and low risk (t¼7.32,
df¼ 41, Po0.000) and moderate/high-risk women (t¼7.58,
df¼ 65, Po0.000) in the novel service arm had made significant
improvements in subjective understanding. There were no
significant differences in the extent to which subjective under-
standing had improved between these groups. Although for
women at low risk in the standard service arm there was an
improvement in subjective understanding between baseline and 4
weeks, this did not reach statistical significance.
Objective understanding There was a significant improvement in
objective understanding of genetics and mammography across all
participants during the study period. Post-hoc tests showed that
scores on these two measures had significantly improved between
baseline and 4 weeks only (genetics: t¼14.37, df¼ 232, Po0.000;
mammography: t¼5.56, df¼ 214, Po0.000).
Cancer worry For all participants, there was a significant
reduction in scores on the Cancer Worry Scale during the course
of the study. Post-hoc analysis revealed that the greatest reduction
in scores occurred between baseline and 4 weeks (t¼ 5.86,
df¼ 239, Po0.000) with a smaller, but nevertheless significant
reduction between 4 weeks and 6 months (t¼ 3.05, df¼ 238,
P¼ 0.003).
General psychological distress Although there was a significant
decrease in the overall proportion of participants suffering from
‘case-level’ distress over the study period (Cochran’s Q¼ 11.44,
df¼ 2, P¼ 0.003), further investigations showed that the reduction
was only significant between baseline and 4 weeks (McNemar
w2¼ 8.27, P¼ 0.004). There were no significant differences in the
proportion of women suffering from ‘case-level’ distress between
trial arms or risk groups at the three assessment points.
Perceived risk of breast cancer There were significant changes in
perceived risk of breast cancer across all subjects over the
study period (Cochran’s Q¼ 10.5, df¼ 2, P¼ 0.005). Further
analysis showed that these changes were only significant between
baseline and 4 weeks where significantly less women perceived
their risk as low at 4 weeks (P¼ 0.011). There were no significant
differences in perceived risk by trial arm at the three assessment
points. However, a significantly greater proportion of women at
low objective risk of breast cancer than those at moderate/high
objective risk perceived their risk to be low at 4 weeks (w2¼ 19.94,
df¼ 1, Po0.000) and 6 months (w2¼ 12.24, df¼ 1, P¼ 0.002).
Comparison of trial arms on health behaviours
At 4 weeks, proportionately more women in the standard service
arm reported examining their breasts every month as recom-
mended (32 vs 23%) and proportionately more women in the novel
service arm reported examining their breasts more frequently than
once per month (11 vs 4%; w2¼ 9.86, df¼ 4, P¼ 0.043). There were
no significant differences between the two trial arms in the extent
to which participants reported performing health behaviours prior
to genetic counselling or reported a change in these behaviours
after counselling. At 6 months, there were no significant
differences between the two groups in the proportion of women
who reported changing any of their health behaviours in the last 6
months.
DISCUSSION
The present study responded to an urgent need for empirical
evidence to inform the development of cancer genetics services in
South East Scotland. A novel community-based service to provide
genetic risk counselling for women with a family history of breast
cancer was compared to the existing standard regional service.
The initial response rate to invitations to participate was good
with 75% of the women invited agreeing to take part in the trial.
The participation rates at each assessment point were satisfactory
(baseline: 87%; 4 weeks: 74%; 6 months: 71%) with 65% of those
enrolled in the trial completing all three questionnaires. The
amount of data lost due to administrative reasons was comparable
across the trial arms.
Women who dropped out of the study tended to be in the novel
service arm of the trial or at low risk of breast cancer. The latter
finding is not unexpected since these women may have been less
motivated to continuing participating in a study of cancer genetics
services which they were ineligible to receive. However, the women
who dropped out of the study had greater levels of psychological
distress. As these women may have dropped out in an effort to
reduce their high levels of distress, they could perhaps benefit from
further psychological intervention. Similar findings have been
demonstrated by a previous trial of cancer genetics services (i.e.
Brain et al, 2000). Given these potential participation biases, the
results should be interpreted with caution in regard to their
generalisability to a wider population.
The cluster randomisation strategy resulted in comparable trial
arms at baseline in terms of sociodemographic and psychological
characteristics. However, a greater proportion of women in the
novel service arm were assigned a low risk of breast cancer.
Further investigation is warranted to determine if this finding is
due to chance or differences between the trial arms in terms of the
method of risk assignment or the accuracy of family history details
reported by participants.
At baseline, subjectively rated understanding of issues related to
breast cancer genetic risk was relatively low (mean scores¼ 9.4 for
the standard service arm /8.9 for the novel service arm out of a
possible 16) and this was reflected in the objective assessment of
understanding. On average, correct responses were given to about
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one-third of the breast cancer genetics items and to about two-
thirds of the mammography items. About one-third of participants
were suffering from ‘case-level’ distress. This is comparable to the
findings in other samples of women prior to genetic risk
counselling using the same measure and threshold (Cull et al,
1999, 2001) and to published data from the general population
(Goldberg and Williams, 1988). Mean scores on the Cancer Worry
Scale were similar to those reported in women prior to genetic risk
counselling by Watson et al (1998) and Brain et al (2000) and
slightly lower than those reported by Hopwood et al (2001) and
Bish et al (2002).
The findings show that after consulting cancer genetics services,
many of the short-term improvements in psychological outcomes
experienced across participants were maintained up to 6 months. All
participants reported greater subjective understanding of issues
related to breast cancer risk and these improvements were most
marked up to 4 weeks and were generally sustained up to 6 months.
However, for the women at low risk of breast cancer in the standard
service arm of the trial, unlike all other participant groups, these
improvements did not reach statistical significance. This may be due
to the fact that the majority of these women received a letter informing
them about their low risk and were not offered a face-to-face
consultation. Improvements in subjective understanding across
participants were reflected by improvements in objective under-
standing which were again most evident between baseline and 4 weeks
and were commonly maintained at a similar level up to 6 months.
Although participants at low risk of breast cancer in the standard
service arm did not feel that their subjective understanding had
improved as much as the other participants, there were no differences
between trial arms or risk groups in significant improvements on
objectively assessed understanding.
It was reassuring to find that despite improvements in objective
knowledge, the proportion of women suffering from ‘case-level’
distress decreased up to 4 weeks and cancer worry continued to
decrease up to 6 months. Unlike previous research that found
significant reductions in cancer worry only for those women at low
or moderate risk of breast cancer (i.e. Brain et al, 2002), reductions
in cancer worry in the present study were not dependent on
objective risk.
Women’s perceptions of their risk of breast cancer were altered
during the course of the study with significantly fewer women
overall perceiving their risk as low at 4 weeks, than at baseline.
More women who were informed about a low risk of breast cancer
perceived their risk of breast cancer as low following their risk
assessment, as may be expected. Similar findings have been
reported elsewhere (Bish et al, 2002). This suggests that the
accuracy of perceived risk for the low-risk group improved during
the course of the study. However, given the fact that responses to
only one of the ad-hoc items were analysed for the purposes of this
report and the accuracy of participants’ risk perceptions was not
assessed in this study, it is difficult to make any firm conclusions
from these results. However, there is no evidence to suggest that
learning that your risk of developing breast cancer is greater than
you believed prior to genetic risk counselling causes psychological
distress (Cull et al, 1999; Watson et al, 1999).
This study has shown that the novel community-based model of
breast cancer genetics services is generally comparable to the
existing standard regional service in terms of the psychological
outcomes experienced by recipients. Therefore, decisions regard-
ing the implementation of the novel model of services should be
based on additional factors such as the resources required and
Table 3 Repeated measures ANOVA for trial arm time objective breast cancer risk on psychological
characteristics
Variable Effect F df P
Subjective understanding Trial arm 0.244 1 0.622
Time 107.82 1.675 0.000**
Trial arm time 2.092 1.675 0.133
Risk 3.915 1 0.049*
Trial arm risk 0.032 1 0.859
Time risk 6.705 1.675 0.003*
Trial arm time risk 3.234 1.675 0.049*
Objective understanding: Genetics Trial arm 0.459 1 0.499
Time 105.741 1.789 0.000**
Trial arm time 0.474 1.789 0.601
Risk 3.31 1 0.07
Trial arm risk 0.708 1 0.401
Time risk 0.923 1.789 0.389
Trial arm time risk 2.573 1.789 0.084
Objective understanding: Mammography Trial arm 0.909 1 0.341
Time 17.713 1.9 0.000**
Trial arm time 2.051 1.9 0.133
Risk 0.857 1 0.356
Trial arm risk 0.068 1 0.794
Time risk 0.894 1.9 0.405
Trial arm time risk 1.681 1.9 0.189
Cancer worry Trial arm 0.117 1 0.733
Time 36.9 1.62 0.000**
Trial arm time 0.535 1.62 0.549
Risk 0.525 1 0.47
Trial arm risk 0.001 1 0.97
Time risk 0.127 1.62 0.838
Trial arm time risk 2.675 1.62 0.082
*Po0.05. **Po0.001.
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client satisfaction with the service. These factors have been
investigated and will be published separately.
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